Cholelithiasis News and Research

RSS
Gallstones, statins increase risk of acute pancreatitis, shows study

Gallstones, statins increase risk of acute pancreatitis, shows study

FDA approves Novo Nordisk’s weight loss injection, Saxenda

FDA approves Novo Nordisk’s weight loss injection, Saxenda

Novartis announces FDA approval of Signifor LAR for treatment of patients with acromegaly

Novartis announces FDA approval of Signifor LAR for treatment of patients with acromegaly

Researchers recommend laparoscopic surgical removal of gallbladder for pediatric patients

Researchers recommend laparoscopic surgical removal of gallbladder for pediatric patients

Ipsen submits Supplemental New Drug Application to FDA for Somatuline Depot 120mg injection

Ipsen submits Supplemental New Drug Application to FDA for Somatuline Depot 120mg injection

Novartis presents Phase III results of Signifor LAR therapy in patients with acromegaly

Novartis presents Phase III results of Signifor LAR therapy in patients with acromegaly

Synageva BioPharma reports study results of sebelipase alfa in adults with late onset LAL Deficiency

Synageva BioPharma reports study results of sebelipase alfa in adults with late onset LAL Deficiency

Synageva announces 12-week data from sebelipase alfa Phase I/II study on LAL Deficiency

Synageva announces 12-week data from sebelipase alfa Phase I/II study on LAL Deficiency

FDA approves Novartis Signifor injection for treatment of Cushing's disease

FDA approves Novartis Signifor injection for treatment of Cushing's disease

FDA EMDAC votes unanimously in support of Signifor use for treatment of Cushing's disease

FDA EMDAC votes unanimously in support of Signifor use for treatment of Cushing's disease

Amgen, Pfizer present Enbrel new trial results against psoriasis at 69th AAD meeting in New Orleans, LA

Amgen, Pfizer present Enbrel new trial results against psoriasis at 69th AAD meeting in New Orleans, LA

VYTORIN reduces major vascular events in patients with chronic kidney disease

VYTORIN reduces major vascular events in patients with chronic kidney disease

Novartis' SOM230 reduces cortisol levels in Cushing's disease patients

Novartis' SOM230 reduces cortisol levels in Cushing's disease patients

Research indicates that acute hepatocellular injury in cholelithiasis and cholecystitis without choledocholithiasis is mild and transient

Research indicates that acute hepatocellular injury in cholelithiasis and cholecystitis without choledocholithiasis is mild and transient

Nanobac announces Baylor initial results for nanoparticle and gall stone formation study

Nanobac announces Baylor initial results for nanoparticle and gall stone formation study

Estrogen therapy may increase risk for gallbladder disease

Estrogen therapy may increase risk for gallbladder disease